- Consumer Products
- Latest 4.63
- Currency US$
- Change 0.06
- Percent Change 1.313 %
- Volume 1,001,111
- Wed Sep 17, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Aug 7||$-0.24||Nov 6||$-0.19|
12 months ended Sep 18, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1ß with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.